COVID-19 Implications for Biopharma Presentations June 25, 2020 Jonathan Kfoury Anne Dhulesia Ben Faircloth
Related Practice Life Sciences & Pharma This report highlights how biopharma executives should adapt to the evolving biopharma landscape in both the nearer and longer term. 01262022160113
Published Articles Mental and Behavioral Health Translating Trips to Trials: Current Challenges in Psychedelics' Clinical Development (p… August 1, 2022
Published Articles Business Services In A Fast-Changing World, Boards Of Directors Must Adapt March 17, 2022
Executive Insights Organization & Performance Matching Integration Strategy and IMO Team Structure May 26, 2022
Executive Insights Biotech and Pharmaceuticals Realising the Promise of Omnichannel Engagement December 16, 2022